XML 49 R27.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

NET INCOME (LOSS) PER SHARE | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
NET INCOME (LOSS) PER SHARE | NOTE 11. NET INCOME (LOSS) PER SHARE The following table sets forth the computation of basic and diluted income (loss) per share: SCHEDULE OF NET LOSS PER SHARE
|  | Three Months Ended March 31, |
|  | 2024 |  |  | 2023 |
Numerator: |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 11,264,842 |  |  | $ | (30,756,144 | )
Less: Cumulative undeclared Series A dividends |  |  | (1,370 | ) |  |  | — |
Less: Undistributed earnings allocated to participating securities |  |  | (756,606 | ) |  |  | — |
Net income (loss) attributable to common stockholders |  | $ | 10,506,866 |  |  | $ | (30,756,144 | )
Net income (loss) |  | $ | 11,264,842 |  |  | $ | (30,756,144 | )
Less: Cumulative undeclared Series A dividends |  |  | (1,370 | ) |  |  | — |
Less: Convertible promissory note interest |  |  | 155,786 |  |  |  | — |
Less: Convertible promissory note change in fair value |  |  | (48,468,678 | ) |  |  | — |
Net loss attributable to common stockholders, diluted |  | $ | (37,049,420 | ) |  | $ | (30,756,144 | )
Denominator: |  |  |  |  |  |  |  |
Weighted average common stock outstanding, basic |  |  | 137,333,802 |  |  |  | 119,999,989 |
Net income (loss) per share attributable to common stockholders, basic |  | $ | 0.08 |  |  | $ | (0.26 | )
Weighted average common stock outstanding, basic |  |  | 137,333,802 |  |  |  | — |
Effect of potentially dilutive convertible promissory notes |  |  | 5,053,849 |  |  |  | — |
Total potentially dilutive securities |  |  | 5,053,849 |  |  |  | — |
Weighted average common stock outstanding, diluted |  |  | 142,387,651 |  |  |  | 119,999,989 |
Net loss per share attributable to common stockholders - basic and diluted |  | $ | (0.26 | ) |  | $ | (0.26 | )
Net loss per share attributable to common stockholders - diluted |  | $ | (0.26 | ) |  | $ | (0.26 | )
As of March 31, 2024 and 2023, the Company’s potentially dilutive securities included Series A Preferred Stock, outstanding public warrants and convertible promissory notes on an as-converted basis. Series A and Restricted Stock are participating securities as Series A is entitled to participate in dividends and in earnings (but not losses) of the Company on an as-converted basis as common shares and the Restricted Stock holder is entitled to participate in any dividends declared on common stock. Accordingly, undistributed earnings are allocated to common shares and participating securities based on the weighted-average shares of each class outstanding during the period. See Note 8 and Note 9 for additional rights and privileges of Restricted Stock and Series A, respectively. Restricted Stock are excluded from the weighted average common stock outstanding pending the achievement of underlying service conditions. The Company excluded the following potential shares from the computation of diluted net loss per share because including them would have had an anti-dilutive effect: SCHEDULE OF ANTI-DILUTIVE NET LOSS PER SHARE
|  | March 31, |
|  | 2024 |  |  | 2023 |
Outstanding restricted stock units (a) |  |  | 3,751,622 |  |  |  | 10,355,527 |
Restricted Stock |  |  | 19,348,954 |  |  |  | - |
Public warrants |  |  | 17,250,000 |  |  |  | — |
Private warrants |  |  | 725,000 |  |  |  | — |
Convertible promissory notes (b) |  |  | — |  |  |  | 2,946,336 |
Earnout Shares |  |  | 24,500,000 |  |  |  | — |
Total |  |  | 65,575,576 |  |  |  | 13,301,863 |
(a) | As of March 31, 2024, there were an additional 7,148,506 restricted stock units that had vested but had not been legally settled into common stock and therefore were included in the basic net income per share. See Note 8 for additional information.
(b) | The number of shares were determined based on the conversion upon maturity provisions in the convertible promissory note agreements, dividing the conversion amount (principal plus accrued interest) by three times the estimated fair value of the Company’s common stock derived from the Company’s most recently completed convertible promissory notes valuation as of the balance sheet date.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration